Emcure Pharmaceuticals IPO is to open on July 3. Emcure Pharmaceuticals is a Mainline IPO to raise ā¹1952.03 crores via IPO. The Emcure Pharmaceuticals IPO price band is fixed at ā¹960 to ā¹1008 with a market lot of 14 Shares. EEmcure Pharmaceuticals is an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. They are a research and development (R&D) driven company with a differentiated product portfolio that includes orals, injectables, and biotherapeutics, which has enabled them to reach a range of target markets across over 70 countries, with a strong 218 presence in India, Europe, and Canada.
What is Emcure Pharmaceuticals IPO GMP Today?
The Emcure Pharmaceuticals IPO GMP aka Grey Market Premium is ā¹300.
What is Emcure Pharmaceuticals IPO Kostak Rates Today?
The Emcure Pharmaceuticals IPO Kostak Rate is ā¹-.
What is Emcure Pharmaceuticals IPO Subject to Sauda Price Today?
The Emcure Pharmaceuticals IPO subject to sauda rates is ā¹3000.
Emcure Pharmaceuticals IPO Expected Returns?
The Emcure Pharmaceuticals expected return is 30%.
Emcure Pharmaceuticals IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | Kostak | Subject to |
| Today | ā¹300 | ā¹- | ā¹3000 |
| 09 July | ā¹360 | ā¹- | ā¹3500 |
| 08 July | ā¹360 | ā¹- | ā¹3500 |
| 06 July | ā¹330 | ā¹- | ā¹3500 |
| 05 July | ā¹330 | ā¹- | ā¹3500 |
| 04 July | ā¹330 | ā¹- | ā¹3500 |
| 03 July | ā¹295 | ā¹- | ā¹3000 |
| 02 July | ā¹285 | ā¹- | ā¹2800 |
| 01 July | ā¹260 | ā¹- | ā¹2500 |
| 30 June | ā¹300 | ā¹- | ā¹2500 |
| 29 June | ā¹300 | ā¹- | ā¹2500 |
| 28 June | ā¹300 | ā¹- | ā¹2500 |
| 27 June | ā¹- | ā¹- | ā¹- |
Emcure Pharmaceuticals IPO GMP aka Grey Market Premium FAQs:
What is Emcure Pharmaceuticals IPO GMP Today?
Emcure Pharmaceuticals IPO GMP is ā¹300 as of today.
What is Emcure Pharmaceuticals IPO Kostak Rate Today?
Emcure Pharmaceuticals IPO Kostak Rate is ā¹- as of today.
What is Emcure Pharmaceuticals IPO Subject to Sauda Today?
Emcure Pharmaceuticals IPO Subject to Sauda is ā¹3000 as of today.
What is Emcure Pharmaceuticals IPO Expected Returns?
Emcure Pharmaceuticals IPO Expected Returns is 30%.
Disclaimer:
- IPO Grey Market Premium (Emcure Pharmaceuticals IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
